Absolute neutrophil count (ANC) >= /uL Absolute neutrophil count (ANC) >= ,/ul Absolute neutrophil count (ANC) >= ,/uL, obtained within weeks prior to randomization Peripheral absolute neutrophil count (ANC) >= /uL Peripheral absolute neutrophil count (ANC) >= /uL Absolute neutrophil count (ANC) >= /uL (>= . X ^/L), within days of registration Absolute neutrophil count (ANC) >= /ul Absolute neutrophil count (ANC) >= /uL Absolute neutrophil count (ANC) >= ,/uL Peripheral absolute neutrophil count (ANC) >= /uL Absolute neutrophil count (ANC) >= ,/uL Absolute neutrophil count (ANC) >= /uL, within days of registration Absolute neutrophil count (ANC) ? /uL Absolute neutrophil count (ANC) >= ,/uL Absolute neutrophil count (ANC) >= /uL Absolute neutrophil count (ANC) >= /uL Peripheral absolute neutrophil count (ANC) >= /uL Absolute neutrophil count (ANC) ? /uL Absolute neutrophil count (ANC) >= ,/uL Absolute neutrophil count (ANC) >= /uL performed within days prior to the date of registration Absolute neutrophil count (ANC) >= ,/uL Absolute neutrophil count (ANC) ? ,/uL within days prior to registration Within days prior to registration: Absolute neutrophil count (ANC) >= ,/uL Absolute neutrophil count (ANC) >= /uL Absolute neutrophil count (ANC) >= ,/uL Absolute neutrophil count (ANC) >= ,/uL Absolute neutrophil count (ANC) >= /uL INCLUSION - TREATMENT: Absolute neutrophil count (ANC) >/ul Peripheral absolute neutrophil count (ANC) >= /uL Absolute neutrophil count (ANC) >= /uL Absolute neutrophil count (ANC) >= /uL. Absolute neutrophil count (ANC) >= ,/uL within days prior to first dose of protocol-indicated treatment. Absolute neutrophil count (ANC) < ,/uL Absolute neutrophil count (ANC) > ,/uL Within days prior to the start of study treatment: Absolute neutrophil count (ANC) >= /uL Absolute neutrophil count (ANC) >= ,/mm^, performed within days prior to day of protocol therapy\r\n* Filgrastim can be given prior to enrollment to achieve target ANC >= /uL Absolute neutrophil count (ANC) >= ,/uL Within days prior to treatment start: Absolute neutrophil count (ANC) >= /ul Absolute neutrophil count (ANC) > ,/uL. Absolute neutrophil count (ANC) >= ,/uL Absolute neutrophil count (ANC) >= . k/uL Absolute neutrophil count (ANC) >= /uL Absolute neutrophil count (ANC) >= ,/ uL, within weeks of registration Peripheral absolute neutrophil count (ANC) >= /uL Absolute neutrophil count (ANC) >= /uL Absolute neutrophil count (ANC) >= . x ^/L (>= /uL) Absolute neutrophil count (ANC) > /ul Absolute neutrophil count (ANC) >= ul Absolute neutrophil count (ANC) >= ul. Absolute neutrophil count (ANC) > /uL Absolute neutrophil count (ANC) > K/uL. ANC (Absolute neutrophil count) >= /ul (unsupported) Absolute neutrophil count (ANC) . x ^/L (,/uL) Absolute neutrophil count (ANC) > ,/uL unless disease-related (due to marrow infiltration or splenomegaly) Absolute neutrophil count (ANC) >= ,/uL Within days prior to enrollment: Absolute neutrophil count (ANC) >= ,/uL Absolute neutrophil count (ANC) of >= ,/uL Absolute neutrophil count (ANC) < /uL Absolute neutrophil count (ANC) >= /ul within days of cycle day absolute neutrophil count (ANC) >= /ul Absolute neutrophil count (ANC) > ,/uL Absolute neutrophil count (ANC) >= ,/ul Absolute neutrophil count (ANC) >= ,/ uL, within weeks of registration (except where specified otherwise) Absolute neutrophil count (ANC) =< ,/uL Absolute neutrophil count (ANC) >= /uL Absolute neutrophil count (ANC) >= /ul Peripheral absolute neutrophil count (ANC) >= /uL Within days of registration: Absolute neutrophil count (ANC) >= /ul Absolute neutrophil count (ANC) >= /uL; filgrastim can be given before and during treatment to achieve target ANC >= uL To be performed within business days prior to day : Absolute neutrophil count (ANC) >= ,/mm^; filgrastim can be given prior to enrollment to achieve target ANC >= /uL Absolute neutrophil count (ANC) >= ,/uL (performed within days of registration) Absolute neutrophil count (ANC) > /uL should be obtained within days prior to enrollment Absolute neutrophil count (ANC) >= /uL Absolute neutrophil count (ANC) >= /uL at screening visit Absolute neutrophil count (ANC) > /uL Absolute neutrophil count (ANC) >= /uL Absolute neutrophil count (ANC) >= ,/uL Absolute neutrophil count (ANC) >= /uL Absolute neutrophil count (ANC) or atypical glandular cell (AGC) >= per uL Peripheral absolute neutrophil count (ANC) >= ,/uL Recovery from induction therapy (absolute neutrophil count [ANC] > /ul, platelet count > ,/ul) Absolute neutrophil count (ANC) < /ul prior to treatment Absolute neutrophil count (ANC) > /uL Patients must have absolute neutrophil count (ANC) >= /uL; neupogen can be given before and during treatment to achieve target ANC >= /uL Absolute neutrophil count (ANC) >= /uL Absolute neutrophil count (ANC) >= /ul Absolute neutrophil count (ANC) >= ,/uL Absolute neutrophil count (ANC) should be > /uL Absolute neutrophil count (ANC) > /uL Absolute neutrophil count (ANC) >= /uL Within days prior to study entry: Absolute neutrophil count (ANC) >= /uL Absolute neutrophil count (ANC) >= ,/uL Absolute neutrophil count (ANC) >= ,/ul Absolute neutrophil count (ANC) > ,/ul Must be met within days of CD: Absolute neutrophil count (ANC) >= ,/ul Absolute neutrophil count (ANC) of >= /uL Absolute neutrophil count (ANC) >= /uL Absolute neutrophil count (ANC) >= ,/uL, performed within days prior to registration Absolute neutrophil count (ANC) < /uL Absolute neutrophil count (ANC) >= /uL Peripheral absolute neutrophil count (ANC) ? /uL Absolute neutrophil count (ANC) >= ,/uL Absolute neutrophil count (ANC) >= ,/uL Absolute neutrophil count (ANC) greater than /uL Absolute neutrophil count (ANC) >= . x ()uL Absolute neutrophil count (ANC) >= /uL Absolute neutrophil count (ANC) >= /uL Absolute neutrophil count (ANC) >= /ul Absolute neutrophil count (ANC) > ,/ul Absolute neutrophil count (ANC) > /uL Absolute neutrophil count (ANC) >= uL Absolute neutrophil count (ANC) > ,/uL Absolute neutrophil count (ANC) >= , /uL Absolute neutrophil count (ANC) >= /uL Peripheral absolute neutrophil count (ANC) >= /uL Absolute neutrophil count (ANC) >= ,/uL Absolute neutrophil count (ANC) =< /ul Absolute neutrophil count (ANC) > ,/ul Absolute neutrophil count (ANC) >= ,/ul Absolute neutrophil count (ANC) >= ,/ul within days prior to starting treatment Absolute neutrophil count (ANC) > ,/uL Patients must have an absolute neutrophil count (ANC) > /ul and a platelet count > ,/ul Absolute neutrophil count (ANC) >= /ul Absolute neutrophil count (ANC) >= /ul Peripheral absolute neutrophil count (ANC) >= ,/uL Absolute neutrophil count (ANC) >= /uL Absolute neutrophil count (ANC) >= /uL Absolute neutrophil count (ANC) >= /uL Absolute neutrophil count (ANC) >= ,/uL Absolute neutrophil count (ANC) >= /uL Peripheral absolute neutrophil count (ANC) >= ,/uL Absolute neutrophil count (ANC) >= /uL Absolute neutrophil count (ANC) >= ,/ul Absolute neutrophil count (ANC) > ,/uL Patients must have absolute neutrophil count (ANC) > /uL Absolute neutrophil count (ANC) >= ,/uL Absolute neutrophil count (ANC) >= /uL Absolute neutrophil count (ANC) => /uL Absolute neutrophil count (ANC) >= ,/uL Absolute neutrophil count (ANC) >= /uL Absolute neutrophil count (ANC) >= ,/uL Absolute neutrophil count (ANC) >= /uL, specimens must be collected within days prior to the start of study treatment Absolute neutrophil count (ANC) >= /uL Absolute neutrophil count (ANC) >= ,/uL Peripheral absolute neutrophil count (ANC) > ,/uL Absolute neutrophil count (ANC) >= /uL Peripheral absolute neutrophil count (ANC) >= /uL\r\n* If the ANC and/or platelet count are not adequate, but due to bone marrow metastatic disease, these criteria will be waived Absolute neutrophil count (ANC) >= /uL Within days of subject registration: Absolute neutrophil count (ANC) >= /uL Absolute neutrophil count (ANC) > ,/uL Absolute neutrophil count (ANC) >= ,/ul Absolute neutrophil count (ANC) > /uL Peripheral absolute neutrophil count (ANC) >= /uL Absolute neutrophil count (ANC) >= ,/ul Absolute neutrophil count (ANC) >= /uL Absolute neutrophil count (ANC) >= ,/uL Absolute neutrophil count (ANC) >= ,/uL Absolute neutrophil count (ANC) >= ,/uL Absolute neutrophil count (ANC) >= /ul Peripheral absolute neutrophil count (ANC) >= /uL (must not have received filgrastim [G-CSF] within the prior days) Absolute neutrophil count (ANC) >= /uL Absolute neutrophil count (ANC) > ,/ul Absolute neutrophil count (ANC) > ,/ul Absolute neutrophil count (ANC) >= ,/uL Absolute neutrophil count (ANC) >= /uL Absolute neutrophil count (ANC) >= ,/uL Absolute neutrophil count (ANC) >= /uL Absolute neutrophil count (ANC) >= /uL Absolute neutrophil count (ANC) >= /uL Absolute neutrophil count (ANC) >= ,/ul Absolute neutrophil count (ANC) >= /ul Absolute neutrophil count (ANC) >= ,/uL Absolute neutrophil count (ANC) ? /uL Absolute neutrophil count (ANC) >= ,/uL Absolute neutrophil count (ANC) >=/microlitre (uL). Absolute neutrophil count (ANC) > ,/uL Peripheral absolute neutrophil count (ANC) >= /uL Absolute neutrophil count (ANC) >= /uL Absolute neutrophil count (ANC) > /uL Absolute neutrophil count (ANC) should be > /uL Absolute neutrophil count (ANC) >= /uL Absolute neutrophil count (ANC) >= /uL Absolute neutrophil count (ANC) >= /ul Absolute neutrophil count (ANC) > K/uL independent of transfusion support Absolute neutrophil count (ANC) >= ,/uL Absolute neutrophil count (ANC) >= ,/uL Absolute neutrophil count (ANC) >= /uL Absolute neutrophil count (ANC) > /uL Within weeks of administration of study therapy: Absolute neutrophil count (ANC) >= ,/uL Absolute neutrophil count (ANC) > uL Absolute neutrophil count (ANC) > /ul Absolute neutrophil count (ANC) < ,/ul Absolute neutrophil count (ANC) >= ,/uL Absolute neutrophil count (ANC) >= ,/uL Absolute neutrophil count (ANC) >= /ul Absolute neutrophil count (ANC) >= /uL Absolute neutrophil count (ANC) >= /uL Absolute neutrophil count (ANC) >= /uL Peripheral absolute neutrophil count (ANC) >= /uL Absolute neutrophil count (ANC) > /uL AT THE TIME OF INFUSION: Absolute neutrophil count (ANC) > /ul Absolute neutrophil count (ANC) >= /uL Absolute neutrophil count (ANC) >= ,/ul Absolute neutrophil count (ANC) >= /uL COHORT A: Absolute neutrophil count (ANC) >= /uL Absolute neutrophil count (ANC) >= /ul (unsupported) Absolute neutrophil count (ANC) >= / uL Absolute neutrophil count (ANC) >= /ul Absolute neutrophil count (ANC) >= /uL Absolute neutrophil count (ANC) >= /uL Absolute neutrophil count (ANC) >= ,/ul Absolute neutrophil count (ANC) >= /uL Absolute neutrophil count (ANC) >= /uL Absolute neutrophil count (ANC) >= ,/uL Peripheral absolute neutrophil count (ANC) >= /uL Peripheral absolute neutrophil count (ANC) >= /uL Absolute neutrophil count (ANC) >= /uL Absolute neutrophil count (ANC) =< /uL Absolute neutrophil count (ANC) >= /uL Absolute neutrophil count (ANC) >= /ul Absolute neutrophil count (ANC) >= ,/ul (unless due to bone marrow infiltration by tumor in which case ANC >= /ml are allowed) Absolute neutrophil count (ANC) < , /uL Absolute neutrophil count (ANC) >= /uL Peripheral absolute neutrophil count (ANC) >= ,/uL Within days after subjects signed the treatment consent: Absolute neutrophil count (ANC) >= ,/ul Absolute neutrophil count (ANC) >= /uL Absolute neutrophil count (ANC) >= /uL Absolute neutrophil count (ANC) >= ,/ul Absolute neutrophil count (ANC): >= /uL (~ x ^/L) Absolute neutrophil count (ANC) >= /uL Absolute neutrophil count (ANC) >= ,/uL Absolute neutrophil count (ANC) >= /uL Patients must have an absolute neutrophil count (ANC) >= /uL Absolute neutrophil count (ANC) >= ,/ul Absolute neutrophil count (ANC) >= ,/ul Absolute neutrophil count (ANC) >= /uL Within days prior to enrollment/randomization: Absolute neutrophil count (ANC) > . K/uL Absolute neutrophil count (ANC) >= . K/uL Absolute neutrophil count (ANC) >= ,/ul (unless low ANC is due to multiple myeloma) Absolute neutrophil count (ANC) > /ul Absolute neutrophil count (ANC) >= /uL Absolute neutrophil count (ANC) > /ul Absolute neutrophil count (ANC) >= ,/uL Absolute neutrophil count (ANC) >= /uL Absolute neutrophil count (ANC) >= ,/uL Absolute neutrophil count (ANC) > ,/uL Absolute neutrophil count (ANC): >= /uL (~. x ^/L) Absolute neutrophil count (ANC) must be >= /uL Absolute neutrophil count (ANC) >= /ul Absolute neutrophil count (ANC) >= /ul Absolute neutrophil count (ANC) >= ,/uL Absolute neutrophil count (ANC): >= ,/ul Absolute neutrophil count (ANC) > ,/ ul Absolute neutrophil count (ANC) >= /uL Absolute neutrophil count (ANC) >= ,/ uL Absolute neutrophil count (ANC) >= /uL Peripheral absolute neutrophil count (ANC) >= /uL Peripheral absolute neutrophil count (ANC) >= /uL Absolute Neutrophil Count (ANC) >= /uL Absolute neutrophil count (ANC) >= /uL Absolute neutrophil count (ANC) >= /uL Absolute neutrophil count (ANC) >= ,/ul Absolute neutrophil count (ANC) >= ,/ul Peripheral absolute neutrophil count (ANC) >= /uL Absolute neutrophil count (ANC) >= /ul Absolute neutrophil count (ANC) >= /uL An absolute neutrophil count (ANC) > /ul Absolute neutrophil count (ANC) >= /uL Absolute neutrophil count (ANC) > /uL not supported by transfusions Absolute neutrophil count (ANC) > . K/uL Absolute neutrophil count (ANC) >= /uL Absolute neutrophil count (ANC) >= /uL Patients must have absolute neutrophil count (ANC) >= /uL; Neupogen can be given prior to start of SGN- (brentuximab vedotin) and during SGN- treatment to achieve target ANC >= /uL Absolute neutrophil count (ANC) >= ,/uL Absolute neutrophil count (ANC) >= ,/uL Absolute neutrophil count (ANC) > /uL Peripheral absolute neutrophil count (ANC) > ,/ul Absolut neutrophil count (ANC) > /uL Absolute neutrophil count (ANC) >= ,/uL Absolute neutrophil count (ANC) > l/ul Absolute neutrophil count (ANC) > /uL Absolute neutrophil count (ANC) >= /uL Absolute neutrophil count (ANC) >=/uL Absolute neutrophil count (ANC) >= ,/uL Absolute neutrophil count (ANC) >= ,/uL Patients with absolute neutrophil count (ANC) >= ,/uL; the most recent ANC level taken within days prior to study enrollment will be considered Have documented lab work with absolute neutrophil count (ANC) >= . K/uL and platelets >= K/uL in the past months Absolute neutrophil count (ANC) >= /uL Absolute neutrophil count (ANC) >= ,/uL Peripheral absolute neutrophil (ANC) >= /uL Absolute neutrophil count (ANC) > /ul Absolute neutrophil count (ANC) >= /uL Absolute neutrophil count (ANC) < , K/UL in the past days Absolute neutrophil count (ANC) greater than /uL Absolute neutrophil count (ANC) < , K/UL in the past days Neutropenia (serum absolute neutrophil count [ANC] < ,/uL) Absolute neutrophil count (ANC) >= ,/uL, obtained within days prior to treatment start Within days of eligibility confirmation: Absolute neutrophil count (ANC) >= , uL Absolute neutrophil count (ANC) ? /uL Peripheral absolute neutrophil count (ANC) >= /uL (must not have received G-CSF [filgrastim] within the prior days) Absolute neutrophil count (ANC) >= ,/uL Absolute neutrophil count (ANC) > /ul Absolute neutrophil count (ANC) ? /uL Absolute neutrophil count (ANC) ?/mm (?. /uL)